Delavirdine: Clinical Pharmacokinetics and Drug Interactions

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.40, Iss.3, 2001-01, pp. : 207-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Duloxetine: Clinical Pharmacokinetics and Drug Interactions

By > Lobo Evelyn Chappell Jill Bergstrom Richard

Clinical Pharmacokinetics, Vol. 50, Iss. 5, 2011-05 ,pp. : 281-294

Adis International

Access to resources Recommend Favorite

Fosamprenavir: Clinical Pharmacokinetics and Drug Interactions of the Amprenavir Prodrug

By Mary Beth Wire

Clinical Pharmacokinetics, Vol. 45, Iss. 2, 2006-01 ,pp. : 137-168

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Metabolic Drug Interactions

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 5-20

Bentham Science Publishers

Access to resources Recommend Favorite

Population Pharmacokinetics of Delavirdine and N -Delavirdine in HIV-Infected Individuals

By Patrick F. Smith Robert DiCenzo

Clinical Pharmacokinetics, Vol. 44, Iss. 1, 2005-01 ,pp. : 99-109

Adis International

Access to resources Recommend Favorite

Ezetimibe: A Review of its Metabolism, Pharmacokinetics and Drug Interactions

By Kosoglou Teddy

Clinical Pharmacokinetics, Vol. 44, Iss. 5, 2005-01 ,pp. : 467-494

Adis International

Access to resources Recommend Favorite